3 years ago

Genome Writing Company Replay Raises $55 Million in Seed Funding

  • Replay, a genome writing company based in San Diego, CA and London, UK, has raised $55 million in seed funding

  • The round was led by KKR and OMX Ventures, with participation from ARTIS Ventures, Lansdowne Partners, SALT, DeciBio Ventures, and Axial

  • Replay has assembled a toolkit of platform technologies to address scientific challenges limiting clinical progress and preventing genomic medicine from realizing its full potential

  • The company has also established an enzyme writing product company engaging its evolutionary inference machine learning and genome writing technology to optimize functionality.

      • ProblemTechnology

      "Reprogramming biology by writing and delivering big DNA to address scientific challenges limiting clinical progress and preventing genomic medicine from realizing its full potential."

      Solution

      "Replay has assembled a toolkit of platform technologies to write and deliver big DNA, including a high payload capacity HSV platform, a hypoimmunogenic platform, and a genome writing platform, and has also established an enzyme writing product company."

      Covered on